For decades, the laboratory mouse (Mus musculus) has been the preferred model organism for the study of human biology and diseases. Humans and mice share a similar genetic background, and around 90% of both genomes can be partitioned into regions of conserved synteny 1 . Although other organisms, such as yeasts, worms and flies, are excellent models for studying basic biological processes, mice are far better tools for prob ing the complex physiological systems that are shared among mammals.
As a result of years of experience 2, 3 and technological advances 4 in the generation of mutated mouse strains, hundreds of mouse models are currently available that mimic many human diseases 5 , even those that are not naturally found in mice, such as cystic fibrosis and Alzheimer disease. Over the past few years, the develop ment of CRISPR-Cas9 technology, which allows highly efficient genome editing by sitedirected DNA endo nucleases, has greatly accelerated the generation of mouse models. Gene editing can be performed directly on zygotes, circumventing the need for a germline competent embryonic stem cell line 6 . Mouse models are commonly used for research in diverse fields of biology
, ranging from neuroscience and behavioural research to physiology and cancer research. The most recent official statistics from the European Committee report that just under 11.5 million laboratory animals were used in Europe in 2011, 61% of which were mice 7 . A UK governmental report shows that 1.16 million mice were used in the United Kingdom in 2014, which equates to 60% of the 1.93 million experimental proce dures completed that year 8 , with usage reported to be consistently at a similar level from 2005 onwards.
It is unsurprising that the mouse is the most com monly used species for scientific purposes. Clinical trials in particular rely heavily on nonhuman organ isms to ascertain the safety and efficacy of a drug before it is tested on humans. Nonetheless, drugs often fail in the early phases of clinical trials; for instance, 40% of the drugs investigated between 2003 and 2011 did not proceed to the second phase of testing, and only 10.4% of drug candidates are likely to get US Food and Drug Administration approval 9 . In cancer research specifically, the average rate of successful translation from animal models to human clinical trials is less than 8% 10 , which mimics the difficulties in using mice as xenograft models of cancer 11 . Although many core biological processes and genetic elements are conserved between human and mouse, other biological features have diverged substantially, leading to phenotypic differences and poorly correlated physio logical responses between species. Diverging features can be genomic differences (such as retrotransposition events, gene expansions or gene losses, genomic rear rangements and differences in coding and noncoding sequences) or regulatory differences that affect gene expression and, ultimately, protein levels (such as alter native splicing, enhancer activity, structural elements (for example, chromatin domains) and posttranslational modifications).
Continuous decreases in the cost and technical chal lenges of highthroughput sequencing have led to a growing effort to functionally characterize the human and mouse genomes: to identify what is shared and what has diverged between these two species. To this end, a series of largescale projects have analysed a vast , which aim to build a public resource of human epigenomic data. Other projects that are collecting human and mouse data simultaneously include the FANTOM project 15 , which focuses mostly on cap analysis of gene expression (CAGE) profiles of human and mouse tissue and cell lines, and the ENCODE and Mouse ENCODE projects 16, 17 , which aim to catalogue all functional elements in the human and mouse genomes, respectively.
Characterizing gene expression profiles across multi ple samples and species is instrumental for determining the extent to which the biology of a given organism can be extrapolated to another. Thus, this Review centres on presenting an overview of the main findings of com parative molecular studies between human and mouse, with a focus on comparative transcriptomics, and how these studies illuminate the cases and conditions under which the mouse is a suitable model of human biology. We also discuss the limitations of current approaches, which include incomplete transcriptome characteriza tion and difficulties in identifying homologous pheno types and cell types, and suggest how these can be addressed using emerging technologies.
Human and mouse genomes
As a reflection of its importance as a model organism, the mouse was, in the early 2000s, the second mammalian species to have its genome sequenced after humans 1, 18, 19 . The most recent genome assemblies (GRC38) include 3.1 Gb and 2.7 Gb for human and mouse, respectively (TABLE 1) , with the mouse genome being 12% smaller than the human one. Around 90% of each genome can be partitioned into conserved syntenic regions, and 40% of the nucleotides in human can be aligned to mouse 1 . The remaining 60% of unalignable nucleotides might be attributed to lineagespecific deletion of repeated elements from the ancestral genome, nucleotidelevel insertions and deletions, and lineagespecific duplications.
Box 1 | Mice as models for human diseases
Since the early days of mouse research, mice have been engineered to generate models for various human diseases and conditions 154 . The Jackson Laboratory has generated more than 5,000 mouse models with different genotypes for almost 1,500 human diseases 5 . Their range of application is broad and includes neurological and muscular disorders, genetic illnesses, behavioural and cognitive abilities, response to viruses and cancer research.
Genetic mouse models of neurodegenerative disorders, such as Alzheimer disease (Online Mendelian Inheritance in Man (OMIM) 104300) 155 and Parkinson disease (OMIM 168600) 156 , which recapitulate the essential features of each disease, have significantly advanced our understanding of the molecular basis of disease progression. However, their translational impact remains limited, as neurodegenerative human diseases are heterogeneous in both pathological and clinical (or behavioural) domains, and the non-hereditary causes (which affect most cases) are unknown . As another example, several mouse models for Down syndrome (also known as trisomy 21, OMIM 190685) have been generated on the basis of the homology of human chromosome 21 and mouse chromosomes 10, 16 and 17 (REF. 158 ). These models exhibit many of the behavioural, learning and physiological defects associated with the syndrome in humans, and as such have proved to be useful for testing therapies that rescue these alterations 159 . Because mice can be housed in small and controlled spaces, manageable behavioural tests have been creatively devised to reproduce major human behavioural patterns. Examples of behavioural-test applications include studies of anxiety 160, 161 , substance abuse and addiction 162 , and diet 163 . Despite the acknowledged discrepancies between the human and murine immune systems 164 , mouse models are available for investigations of viral infections. These can provide an alternative to costly and more ethically problematic research on primates. For instance, humanized mice derived from the combination of transplantation of human fetal pluripotent haematopoietic stem cells with surgical engraftment of human fetal thymic tissue (BLT mice) have been used to study many aspects of HIV infection, including prevention, transmission and therapies 165 . Similarly, human hepatocytes can be transplanted into immunodeficient mice to develop humanized chimeric mice, which enable the study of viral replication and cellular changes caused by human hepatitis viruses 166 . Finally, mice have also been widely used for the research of complex multifactorial conditions, such as autism 167 and ageing 168 , in which it is crucial to be able to account for one individual factor at a time. Among complex diseases, cancer research is prompting the development of several mouse models to study the relationship between mutations and tumour biology 169 . However, the current limitations of mouse models are well known 170 . The use of mice to study the intricacies of human cancer pathogenesis, for example, is limited by many species differences, including cell duplication time, lifespan and cancer susceptibility 171 . Other examples include mouse models of cystic fibrosis (OMIM 219700), a hereditary lung disease caused by a mutation in the gene encoding the membrane protein cystic fibrosis transmembrane conductance regulator (CFTR). Although mouse models have proved to be useful for discovering ways to correct this genetic defect 172 , cystic fibrosis mouse models have a limited ability to recapitulate spontaneous lung disease 173 . Similarly, mouse models for the progressive muscle-wasting disorder Duchenne muscular dystrophy (OMIM 310200) -that is, mdx mice -have been engineered to study potential gene therapies, but a caveat is that they show only minimal clinical symptoms 174 . Alternative animal models are being investigated to potentiate translational research, and larger mammalian species, such as pigs, ferrets and dogs, are proving to be beneficial for scaling up initial results obtained in mouse models 173, 174 .
GENCODE annotation
The GENCODE project produces high-quality reference gene annotation and experimental validation for human and mouse genomes.
Long non-coding RNAs
(lncRNAs). Non-protein coding transcripts that are longer than 200 nucleotides. This somewhat arbitrary limit distinguishes lncRNAs from small regulatory RNAs.
Orthologous
Homologous genes in different species that have evolved from a common ancestral gene by speciation.
Protein-coding genes. According to one of the latest releases of the GENCODE annotation 20 (v25, Ensembl86), which recently also started to curate the mouse genome 21 (vM11, Ensembl86), the human genome encodes 58,037 genes, of which approximately onethird are protein coding (19, 950) , and yields 198,093 transcripts. By comparison, the mouse genome encodes 48,709 genes, of which about half are proteincoding (22,018 genes), and yields 118,925 transcripts overall (TABLE 1) . For both species, the current number of proteincoding genes is about 10,000 genes lower than was estimated from early genome assembly drafts 1, 18 . The discrepancy in the total number of annotated genes between the two species is unlikely to reflect dif ferences in underlying biology, and can be attributed mostly to the less advanced state of the mouse annota tion. The number of proteincoding and long non-coding RNAs (lncRNAs) encoded in the human and mouse genomes is expected to be similar, and differences in the total genome length do not result from differences in the number of genes, but probably from differences in the lengths of introns and intergenic space 1 (FIG. 1) .
Indeed, when including predicted gene models from RNA sequencing (RNAseq) and CAGE data, the mouse annotation expands to a size that is similar to that of the human annotation 22 . There is a high degree of gene orthology between human and mouse: 80% of human and 72% of mouse proteincoding genes have a onetoone orthologous relationship in the automatically derived Ensembl Compara 23 -15,893 genes in total (FIG. 1) , a num ber that is highly similar to the 15,736 orthologous genes derived after extensive curation efforts by the ENCODE consortium 17 . The remaining 20-30% of protein coding genes are in onetomany or manytomany orthologous relationships, are members of gene fam ilies that have undergone speciesspecific expansions or reductions or contain speciesspecific open reading frames (ORFs). These genes might contribute to human disease phenotypes and should therefore be taken into account when engineering mouse models 1 . For example, the humanspecific gene saitohin (STH), which contains a singlenucleotide polymorphism (SNP), Gln7Arg, that is associated with susceptibility to several neurodegenerative diseases 24 , has no orthologous gene in mice.
Long non-coding RNAs. Evidence for the importance of lncRNAs is continuously growing, and ever more lncRNAs that are related to human diseases are dis covered every year [25] [26] [27] . Identifying the possible mouse ortho logues of human lncRNAs would greatly assist in the elucidation of their biological role.
Currently, there are 15,767 and 9,989 lncRNAs annotated by GENCODE in human and mouse, respec tively 20, 21 . The discrepancy, again, is a consequence of the lesscomplete state of the mouse genome annota tion. lncRNAs are usually expressed at a lower level than proteincoding genes and often in a tissuespecific manner, which hinders their identification and leads to a requirement for additional resources to build a compre hensive annotation 28, 29 . Finding orthologous relationships and conservation estimates for lncRNAs is also more chal lenging because their sequence is less conserved than that of proteincoding genes 28 and not constrained by amino acid translation. In fact, the definition of lncRNA orthol ogy is not as clear as for proteincoding genes and has so far been considered a combination of sequence and/ or functional conservation and synteny 30 . Whereas RNA secondary structure might be useful to identify short noncoding RNAs and their degree of conservation, only a few lncRNAs identified thus far have distinct structural domains as defined in Rfam 31, 32 . Thus, current catalogues of orthologous lncRNAs are still highly incomplete and inaccurate 32 , and the development of methods to identify lncRNA orthology is an active field of investigation.
A number of studies over the past few years have attempted to identify novel lncRNAs in mice and other species and identify their orthologues in humans 22, [33] [34] [35] . Although the gene sets may vary among the different studies, they produce a consistent estimate of approx imately 1,000-2,000 orthologous lncRNAs between human and mouse. Necsulea et al. 34 report the highest number of human-mouse orthologous lncRNAs (2,720) based on sequence similarity of both novel and annotated transcripts, whereas Washietl et al. 35 identify 1,100 orthol ogous lncRNAs based on genomewide chain alignments. Pervouchine et al. 22 reported 851 lncRNA orthologues on the basis of a mixed approach including both genome alignments and sequence homology. A more recent study, . The number of protein-coding orthologues was taken from Ensembl Compara 23 (v86) , and the numbers of orthologous long non-coding RNAs (lncRNAs) were obtained from different sources 22, [34] [35] [36] . snoRNAs, small nucleolar RNAs; snRNAs, small nuclear RNAs. which includes the information on syntenic blocks to call the orthology, reports 1,587 human-mouse orthologous lncRNAs 36 . However, the overlap between these studies is quite low: Pervouchine and colleagues 22 reported that only 189 orthologous lncRNAs are in common between their study and that of Necsulea et al. 34 . In all of these studies, orthologous lncRNAs represent only a small frac tion of all annotated lncRNAs in both species, especially when compared with proteincoding genes.
MicroRNAs
About 5,000 lncRNA transcripts are in antisense orien tation with respect to proteincoding genes in both mouse and human 37 , and antisense transcription is known to have a role in the regulation of expression of the sense gene in a number of cases 38 . For example, an antisense transcript of the tumour suppressor gene CDKN1A recruits a regulatory complex that induces his tone H3 trimethylation at Lys27 (H3K27me3) to suppress the sense promoter region 38 . Although antisense tran scription is largely present in both species, the proportion of orthol ogous sense-antisense pairs relative to all senseantisense pairs is low (less than 20%, around 1,000 pairs 22, 37 ), suggesting low conservation of antisense tran scription, and consequently of the corresponding biology.
Small non-coding RNAs. Compared with protein coding and lncRNAs, small noncoding RNAs, which include microRNAs (mi RNAs), transfer RNAs (tRNAs), small nuclear RNAs and small nucleolar RNAs (snRNAs and snoRNAs), have received less attention in compar ative transcriptomics studies, partially because they are more difficult to monitor, with analyses limited to only a handful of tissues, such as brain, liver, kidney, heart and testis [39] [40] [41] [42] . Small noncoding RNAs are known to be involved in the regulation of RNA processing, expres sion and translation 43, 44 , and there is growing evidence of their involvement in human diseases 27 . For example, alterations in miRNA expression can lead to a range of diseases, including immunerelated diseases (such as multiple sclerosis), neurodegenerative diseases (such as Parkinson disease) 45 and cancer 46 . Thus, the use of specific mouse models to understand the mechanisms of small noncoding RNA involvement in diseases will certainly be beneficial 47 . For example, obese mice defi cient in miR375 developed severe insulindeficient diabetes mellitus, suggesting that miR375 is essential for mediating metabolic stress 47 . Currently, almost 3,000 and 2,000 mi RNAs are anno tated in the human and mouse genome, respectively 48 (TABLE 1) . However, only a small fraction of them (300 mi RNAs) has a defined orthologue in the other species 49 . tRNAs have a peculiar secondary structure that allows them to recognize mRNA codons by pairing to their anticodon and to carry an amino acid cognate to the tRNA 50 . Because of codon degeneracy for the 21 amino acids (including selenocysteine), multiple anticodons are related to the same amino acid (tRNA isoacceptors). Figure 1 | Homology of human and mouse genes and genomic elements. Orthologous genes between human and mouse can be identified on the basis of the sequence homology of coding exons. Orthologous genes tend to have conserved exonic structure and exon lengths, but introns are generally shorter in the mouse. There is some degree of conservation of alternative splicing patterns
, but species-specific splicing events exist. Orthologous genes may have conserved expression profiles between the two species (yellow) or diverged expression (orange). The bar chart represents expression levels of the genes in different organs. Genes with homologous sequence in the same species are called paralogues. Paralogous genes may originate from gene duplication events, and their exonic structure, sequence and expression may diverge with evolutionary time. Promoter sequences (upstream from genes) are less conserved than gene body sequences. Regulatory motifs may differ, although regulatory networks may be conserved. Orthologous genomic regions (and elements; pink) can be identified through whole-genome alignments. However, some elements cannot be aligned to the other species (grey) or can map in multiple locations (brown). Finally, some genomic regions can be aligned, but their function may not be conserved (blue). UTR, untranslated region.
Homologues
A pair of genes that descended from a common ancestral gene.
Hierarchical clustering
A statistical method in which objects (for example, gene expression profiles for different individuals or tissue samples) are grouped into a hierarchy, which is visualized in a dendrogram. Objects close to each other in the hierarchy, as measured by tracing the branch heights, are also close by some measure of distance -for example, between gene expression profiles. Individuals or samples with similar expression profiles will be close together in terms of branch lengths.
Euclidean distance
The Euclidean distance between points p and q is the length of the line segment connecting them in a multidimensional space. In gene expression analysis, p and q are usually vectors of expression values in two samples or conditions.
Dimensionality reduction techniques
These reduce multidimensional data to a minimal number of dimensions for visualization by identifying those dimensions that capture the most important information underlying the data structure.
Principal component analysis
(PCA). Orthogonal linear transformation that transforms the original data to a new coordinate system, such that the greatest variance of the projected data comes to lie on the first coordinate (called the first principal component), the second greatest variance on the second coordinate, and so on.
Multidimensional scaling (MDS).
A technique used to display the information contained in a distance matrix. It aims to place each object in N-dimensional space such that the between-object distances are preserved as well as possible.
Human and mouse share 46 iso acceptors 41 . The num ber of predicted tRNA genes is similar between human and mouse (631 and 471 tRNA genes, respectively) 51 (TABLE 1) , as is the number of tRNA genes detected in human and mouse liver (223 and 224 tRNA genes, respectively) 41 . Although tRNA expression is conserved between the two species at the isotype level (tRNA iso acceptors related to the same amino acid), 34% of mouse tRNA genes cannot be aligned to human homologues, and only 79 tRNA genes are commonly expressed in liver samples 41 , which suggests a certain degree of divergence in the evolution of tRNA genes.
snRNAs are essential elements of the spliceosome, and their expression levels are overall conserved between human and mouse 42 . snoRNAs are needed for the bio chemical modification of specific sites of ribosomal RNA, tRNA and snRNA 43 . Of the 944 and 1,508 anno tated human and mouse snoRNA genes 20 , respectively (TABLE 1) , at least 208 are conserved between the two spe cies 42 . Of these, 63 snoRNA genes (30%) have distinct expression profiles 42 , which indicates that the regulation of snoRNA genes has diverged considerably between the two species.
Further studies will improve our understanding of the regulatory role and evolution of these RNA families, and hopefully of their involvement in diseases. Particularly relevant will be the understanding of the conservation between human and mouse of the relationship between the long precursor RNA molecules and the small func tional RNA products. This, in particular, would extend the possibility of therapeutic interventions along the entire molecular pathway involved in the synthesis of small RNA molecules.
Conservation of transcriptomes
Similarities in the gene sets between two species do not necessarily reflect transcriptomic similarities, as the expression pattern of a gene across tissues and condi tions can be very different across species. With the devel opment of microarray technologies and RNAseq, which enable a genomewide survey of the transcriptional activity of genes, there has been much interest in under standing to what extent the patterns of gene expres sion and splicing (BOX 2) have been globally conserved between human and mouse.
Microarray studies. Most of the early microarray studies focused primarily on the expression of orthologous proteincoding genes in various homologous tissues, such as brain, heart, muscle and liver. Under the assump tion that the mouse is a good model of human biology, one would expect higher similarity of gene expression between the species in homologous organs than in dif ferent organs from the same species 52 . In other words, human liver would have an expression profile resembling that of mouse liver more than that of the human heart.
The relationship of transcriptomes from multiple RNA samples is usually visually represented using meth ods related to hierarchical clustering. In this approach, samples are given as the leaves of a dendrogram that is built on the basis of a given similarity measure between transcriptomes. This measure is usually the Euclidean distance between individual gene expression levels or the correlation coefficient across all genes between samples (FIG. 2) . Alternative methods to visualize tran scriptome relationships include dimensionality reduction techniques, such as principal component analysis (PCA) 53 , multidimensional scaling (MDS) 54 or the more recently developed t-distributed stochastic neighbour embedding (tSNE) 55 . These approaches project samples onto a 2D or 3D space, where their distance from each other is related to overall transcriptome similarity (FIG. 2) .
These statistical methods are heavily dependent on the quality of the input data, how much variation there is between and within samples and how the values are dis tributed. Indeed, the importance of proper filtering and normalization before secondary analysis has been stressed for microarray data, which are known to be subject to several technical biases. Studies that emphasize proper use of normalization methods report a high conserva tion of expression between human and mouse tissues 52, 56 , such as brain, muscle, liver, kidney, lung and spleen, after correcting for arrayspecific differences in expression. By contrast, inaccurate normalization -for instance, failing to account for speciesspecific systematic bias in signal intensity values in microarray probe setshas been shown to spuriously exacerbate differences between species 57, 58 . It is still under debate whether the results support ing transcriptional conservation between humans and mice, which were obtained in a limited number of sam ples, are generally applicable to any type of sample and to the transcriptome as a whole. For example, although the induction and repression of major transcriptional regulators of erythropoiesis are conserved between mouse and human, significant transcriptional diver gence between the two species has been detected at the transcriptome level 59 . Many transcriptional differences were also reported at the level of the immune and inflammatory response. These might be explained by cisregulatory differences. For instance, although the macrophage response to bac terial lipopolysaccharide (LPS) is conserved overall between the two species, differential sets of genes are activated and repressed in mouse and human, a transcriptional plas ticity that might be conferred by TATAenriched and CpG islanddepleted promoters 60 . By contrast, intraspecies dif ferences in the macrophage transcriptional response to glucocorticoid seem to be associated with gains and losses of glucocorticoid response elements 61 . In another study, it was shown that mouse transcriptional responses to different inflammatory stresses, including trauma, burns and endotoxaemia, correlate poorly with the human ones, even though human transcriptional responses to different inflammatory stresses correlated well with each other 62 . This finding raised the question of whether the mouse is a good clinical model for studying such condi tions. This conclusion was challenged by a reanalysis of the same data that was restricted to a smaller set of genes with changes in expression levels that were conserved between human and mouse 63 . However, it has been noted that this approach introduces a bias into the results, and t-Distributed stochastic neighbour embedding (t-SNE). A nonlinear dimensionality reduction technique that is based on the probability distribution over pairs of high-dimensional objects that are embedded into a space of two or three dimensions. Similar objects are modelled by nearby points, and dissimilar objects are modelled by distant points.
Normalization
that the low percentage of genes with conserved changes in expression (12%) may itself be indicative of poor reproducibility of the human response in mice 64, 65 .
RNA-seq studies. The introduction of RNAseq technol ogy prompted more comparative transcriptomics studies at a deeper resolution and with larger numbers of spe cies, as RNAseq does not depend on first fabricating a speciesspecific spotted microarray (see REFS 66, 67 for reviews). The advantages of RNAseq over microarray technology include its greater sensitivity, its broader range of detection (from lowly to highly expressed genes) and the ability to detect RNA abundances independently of annotation 68 . The Mouse ENCODE Consortium 69 has been collect ing around 100 RNAseq data sets for a range of mouse tissue and cell types to create a comprehensive reference for future studies 17 . The profiled samples include almost Nature Reviews | Genetics Splicing is the mechanism through which exons and introns of genes are processed into mature coding and non-coding transcripts. Different combinations of exonic and intronic sequences can be arranged through alternative splicing to expand the range of processed isoforms from a relatively limited pool of genes.
Exon structure and splicing are similar between humans and mice in terms of the number and order of exons per gene, exon length, precise boundaries and sequence 175, 176 . The exact number of orthologous exons is heavily dependent on the genome assemblies, the annotation status and the set of analysed genes: the Mouse ENCODE Consortium has annotated more than 150,000 orthologous internal exons 17 , a noticeable increase when compared with the 2,000 exons 177 identified in the earliest reports right after publication of the first complete mouse genome draft. Although alternatively spliced exons with a low proportion of inclusion tend to be more species-specific 175 , exon inclusion levels are overall highly correlated between the two species, even across very distant sample types 22 (see the figure, part a) . Indeed, alternative splicing was shown to be less evolutionarily conserved than gene expression in comparative studies including multiple species and organs 76, 77 . However, comparative analyses of exon inclusion are usually limited to a few hundred conserved exons 76, 77 and are tied to local splicing events instead of considering the whole isoform structure. Determining orthology at the isoform level for complete gene structures of exons and introns is particularly challenging as a result of the presence of non-coding exons, which have fewer sequence constraints than coding sequences, and the redundancy of exonic elements between multiple isoforms of the same gene 178 . Novel transcriptomic sequencing strategies -for example, synthetic long-read sequencing 179 and single-molecule long-read sequencing 180 -have enabled the detection of full-length transcripts and can preserve the relationship between distant exons (see the figure, part b) . These techniques, possibly coupled with targeted approaches for lowly abundant loci, will improve the accuracy of isoform detection and might provide new insights on the conservation of isoform usage and of its regulation across species.
30 tissues taken from adult mice, and the brain, nervous system, limbs and liver of embryos, as well as mouse cell lines, such as embryonic stem cells, murine erythro leukaemia (MEL) cells and mouse lymphoma (CH12) cells. Depending on the sample, they were collected and sequenced at different centres, and at least two repli cates were sequenced for each sample. As in the case of microarrays, the clustering of mouse and human gene expression profiles from homologous tissues strongly depended on the normalization applied 17 . However, because human data from comparable experimental conditions is not available (the bulk of human ENCODE transcriptome data was obtained in cell lines 16 , whereas the mouse data were obtained from primary tissues), it is hard to disentangle the gene expression variation attributable to the species from that resulting from other biological factors or technical effects 17 . Simultaneous analysis of the human and mouse RNA data uncovered a large fraction of orthologous protein coding genes (about 50%) with fairly constrained expres sion, independent from the sampled cell type in both human and mouse 22 . However, analysis of human and mouse gene expression from a more homogeneous experimental setting (where samples were collected, processed and sequenced similarly at the same cen tre) argued that different conclusions can be drawn depending on which organs are profiled: organs with more distinct signatures of tissuespecific genes, such as brain, testis, heart, liver and kidney, showed strong conservation between the two species [70] [71] [72] [73] . By contrast, a study that also included organs expressing fewer tissue specific genes 70 , such as adipose tissue and stomach, showed that transcriptional patterns overall are different between human and mouse, separating the species more than the organs. This conclusion led to a highly charged debate that suggested that other factors and biases, such as sequencing site, time of sequencing and the sequen cing instrument used, need to be taken into account when undertaking comparative transcriptomics 74 . The analysis of additional vertebrate species at differ ent phylogenetic distances to human and mouse, such as macaque, chimpanzee, opossum, platypus and chicken, affirmed the original conclusion that transcriptional patterns are more similar between orthologous organs of different species than between different organs from the same species [75] [76] [77] . These studies, however, were again based on organs expressing the largest numbers of organspecific genes.
Taken together, the studies discussed above suggest that the question of whether the mouse is overall a suit able model of human biology, based on transcriptome comparisons, is illposed. These works implicitly assume an average behaviour for genes, ignoring that each gene has a characteristic pattern of expression variation across species and organs (FIG. 1) . This pattern has recently been investigated both between human and mouse 17 and across multiple species 78 (FIG. 2) . In both studies, linear models were used to decompose the variation of gene expression in a set of homologous adult tissues across human and mouse only or across multiple mammals, including human and mouse, and chicken. Each gene exhibits its own pattern of variation across tissues and species. For example, the expression of the uro modulin gene (UMOD) is variable across tissues but stable between human and mouse, as it shows kidneyspecific expression in both species 17 . By contrast, the gene that encodes calciumbinding and coiledcoil domaincontaining protein 2 (CALCOCO2) exhib its greater variation across species: it has a rela tively constant expression across tissues in human, whereas it is not detected in adult tissues in mouse, although it is expressed during embryonic develop ment 17, 79 . Thus, a subset of genes was identified that varies a lot across tissues, but little across species, lead ing to tissuedominated clustering, whereas another subset of genes varies considerably across species, but little across tissues, leading to a speciesdominated clustering 78 (FIG. 2c) . Vertebrate (mouse) models of human biology may be particularly appropriate for the genes in the tissuedominated clustering 80 . Remarkably, these genes are more likely to be associated with diseases than are genes whose expression varies predominantly across species 78 . lncRNA expression conservation. Most of the large scale comparative studies of gene expression have been centred on orthologous proteincoding genes. Only in the past decade have comparative surveys of non coding transcriptomes emerged as a result of the continuous expansion of lncRNA annotation 20, 21 . Overall, orthologous lncRNAs between human and mouse have conserved levels of expression 22, 33 . However, cluster ing analysis and PCA based on lncRNAs show more rapid evolution of expression patterns compared with proteincoding genes 34 . In addition, the breadth of expres sion is conserved not only between human and mouse but also in other mammals: ubiquitously expressed lncRNAs in human are ubiquitous across all species analysed, and tissuespecific lncRNAs in human are tissuespecific in all species 33, 35 . However, these results might be influenced by the relatively low number of orthologous lncRNAs (less than 10% of all annotated lncRNAs) compared with orthologous proteincoding genes (75% of all annotated proteincoding genes). Most orthologous lncRNAs seem to be testisspecific in human and mouse 33, 35 , especially the less conserved ones 34 . This is hypothetically related to a more permissive chromatin conformation during spermatogenesis 81 , which could potentially contribute to the rapid evolution of testis transcriptomes. Therefore, organspecific evolutionary rates of gene expression must be considered when evaluating whether the mouse transcriptome is a good model of the human transcriptome.
Expression and sequence conservation. A key question in understanding the evolution of gene expression is how it is related to the evolution of sequences and whether conservation of gene expression is reflected in sequence constraints. Overall, average gene expression levels cor relate well between human and mouse, such that highly expressed genes in humans tend to be highly expressed in mice 82, 83 , even when very heterogeneous samples, such as cell lines and tissues, are considered 22 . Conservation of gene expression is to some extent reflected by sequence conservation in the gene body 82, 84 . Promoter sequences, however, have diverged more than gene body sequences between mouse and human. Depending on the method by which promoter sequence conserva tion is quantified -global or local sequence alignments or preserved presence of transcriptionfactorbinding motifs -only a slight correlation between promoter con servation and gene expression conservation is observed 83 . Gene expression is predominantly conserved, even if the sequence of regulatory regions has diverged 85, 86 . This might be due to compensatory mechanisms: for instance, Nature Reviews | Genetics 
DNA exaptation
The shift in the function of a DNA sequence during evolution.
two different transcription factors in the two species acting on the expression of the same gene might activate it at comparable levels despite binding to two different regions 87 .
Comparative gene regulation
Over the past 5 years, comparative studies have tried to move beyond characterizations of differences in gene expression levels within and between species to studying variation in regulatory mechanisms 88 . However, the combinatorial complexity of gene regulatory factors (for example, histone modifications and transcription factors), the use of different sample types (tissues or cell lines) and the difficulties in associating specific regu latory regions with the regulated genes (which may be distal) make it extremely challenging to reach a com prehensive genomewide map of regulatory elements. Most comparative experiments between human and mouse have been confined to a handful of transcription factors in a few cell types [89] [90] [91] [92] [93] . Nonetheless, these studies have revealed principles of cis regulation that have sub sequently been confirmed by larger studies. The Mouse ENCODE Consortium has been collecting chromatin immunoprecipitation followed by sequencing (ChIPseq) data for histone modifications and transcription factor binding sites, DNase sequencing (DNaseseq) data for chromatin accessibility sites and replication timing data for chromatin domains for hundreds of different mouse tissue and cell types 17 . Although chromatin states inferred from histone modifications 94 and chromatin domains were highly similar between the two species, patterns of transcription factor binding, as measured by ChIP-seq and inferred from DNase I hypersensitive sites ('footprints'), were more diverged, with only 22% of transcription factor footprints being conserved 17 .
Transcription factor binding. The primary consensus sequence motif for orthologous transcription factors is almost the same in human and mouse 89, 95 , but secondary motifs often differ 95 . Of the four human secondary motifs with the strongest enrichment in the peaks inferred from transcription factor ChIP-seq experiments, only NRF1 has a totally conserved sequence with mouse secondary motifs 95 . Because secondary motifs often represent the consensus motifs for other transcrip tion factors, the identity of associated factors might be lineagespecific 95 . Thus, the most commonly used motifs in one species may have binding capacity in the other species, with the caveat that the presence of the motif alone is not indicative of actual binding. Depending on the sample and the transcription factor, between half and twothirds of the binding sites in one species can be aligned to a homologous sequence in the other species [95] [96] [97] and widely share the same relative distance to the transcription start site 95 . However, only 10-20% of the transcriptionfactorbound sites in one species are also bound in the other species 95, 97 . Speciesspecific binding sites may arise from species specific innovations or losses (FIG. 1) . Novel transcription factorbinding sites and enhancers can arise from the transposition of repeated elements 17, 92, 98 or by DNA exaptation 99 . Surprisingly, it has been shown that up to 40% of binding sites for the transcription factor CCAAT/enhancerbinding proteinα (CEBPα) that are unbound in human but bound in mouse have an unchanged sequence 91 . By contrast, the loss of tran scription factor binding occupancy in aligned regions is, in about 50% of cases, compensated by another bind ing motif within 10 kb (REF. 91 ), so the main regulatory circuits of gene regulatory networks are maintained. Indeed, tissue and celltypespecific gene regulatory networks of transcription factors in mouse, inferred from genomic DNase I footprints, are highly similar to the networks in human homologous tissues and cell types: more than 40% of the transcription factortranscription factor regulatory connections are con served between the two species 100 . This finding suggests that the conservation of functional regulatory circuitry is considerably greater than that indicated by sequence con servation alone 100, 101 (FIG. 1) . In addition, transcription factorbinding sites in one species are often repurposed in other species; it has been computed that 48% and 57% of homologous sites are bound in the other species for human and mouse, respectively, such that a sequence is bound either by the same transcription factor in a different cell type or by different transcription factors in the same cell type 96 . Furthermore, binding sites with nonconserved occupancy tend to be more tissue specific and are usually in a nonpermissive chromatin state in the species in which they are inactive 95 . Taken together, these findings suggest that although the relationships between transcription factors and their targets are conserved between human and mouse, the activity of specific regulatory DNA elements, such as enhancers and promoters, in one species cannot be inferred in the other species from sequence homology and consensus motifs alone. This is also the case for many lncRNAs, which show speciesspecific expression even if they are located in regions of conserved syn teny 36 . In fact, only functional validation experiments If a human organ (for example, liver or heart) has a more similar gene expression profile to the homologous mouse organ than to another human organ, the clustering is organ-dominated (part a). Vice versa, if human organs have gene expression profiles that are more similar to each other than to their homologous mouse organs, the clustering is species-dominated (part b). The variation of expression for each gene can be decomposed into the most contributing factors, in this case species and organs (part c).
Genes are distributed in a continuous way along these proportions of variation. Nonetheless, genes at the extremes of this distribution can be identified as genes with proportionally higher variation across species and lower variation across organs (orange) and genes with proportionally higher variation across species and lower variation across organs (yellow).
If only the expression of one or the other set of genes is used for clustering, genes with proportionally higher variation across species or organs lead to a more species-dominated clustering or more organ-dominated clustering, respectively. Hierarchical clustering based on real gene expression data 78 from different organs across mammals and chicken, performed with the entire set of orthologous genes across species, reveals organ-dominated clustering (part d). Distances between samples can be visually represented on a two-dimensional space through several dimensionality reduction techniques, such as t-distributed stochastic neighbour embedding (t-SNE) (part e, same input as part d, perplexity = 4, iterations = 1,000), multidimensional scaling (MDS) (part f, same input as part d, Euclidean distance) and principal component analysis (PCA) 78 (g). The image parts d and g are reproduced from REF. 78 ; parts e and f are new figures based on data from REF. 78 .
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Expression quantitative trait loci
(eQTLs). Genomic loci that contribute to variation in the expression levels of mRNAs.
Allele-specific expression
Expression variation between the two haplotypes of a diploid individual, as distinguished by heterozygous sites.
can confirm the reliability of crossspeciespredicted transcriptionfactorbinding sites 102 . Screening strategies have been developed for testing the in vivo activity of enhancers using transgenic mouse embryos, which also allows the assessment of their tissue specificity 103 . Over the years, a freely available database has been assembled containing the results for almost 3,000 tested enhancers that are orthologous between human and mouse 104 .
Inferring human SNP causality from mouse regulatory regions. Ultimately, enhancers and transcription factorbinding sites in mouse can be a good proxy to find functional genomic regions implicated in human traits: for instance, SNPs found in genomewide association studies (GWAS) 105 . Specifically, if a human variant identified in a human GWAS can be mapped to an orthologous region in the mouse genome, its overlap with functional elements in mouse, such as enhancers, can be investigated. Promisingly, more than 4,000 SNPs from human GWAS have been mapped uniquely onto the mouse genome 17 . As an encouraging example, SNPs associated with traits related to liver function (such as highdensity lipoprotein cholesterol levels and alcohol dependence) in humans reside in liverspecific enhancer sequences in mouse 17 . Similarly, SNPs associated with traits related to urate levels in humans reside in kidney specific enhancer elements in mouse 17 . Thus, the mouse can be a useful model for gaining insights into the causality of SNPs identified in human GWAS.
Intraspecies expression variation
Between 4 million and 5 million SNPs differentiate each person from the human reference genome 106 , and a conservative estimate postulates that the genomes of any two individuals differ by at least 0.5% 107 . How this variation affects molecular features, such as gene expres sion and, ultimately, phenotypes, is currently a topic of active research, especially within consortiumled projects such as Geuvadis 108 and GTEx
109
. For instance, the GTEx project identified 199,362 mutations that affected the expression of 27,159 genes in at least one of 44 human tissues (release V6p). The major stratification of variation within humans is at the level of populations. The concept of interindividual variation in laboratory mice is less straightforward, as the M. musculus species has multiple layers of stratification due to human inter vention. Laboratory strains can be classified into classical inbred strains and wildderived strains 110 , with the former being characterized by at least 98.6% homozygous loci in each individual 111 . Classical inbred strains are mosaics of a handful of haplotypes derived from mice generated from wild subspecies 112 , with more than 90% of their genetic background coming from Mus musculus domesticus 110, 113 . To quantify the genetic variation between strains, the Mouse Genomes Project sequenced and catalogued a number of classical inbred and wildderived strains 114 . Variation within the reference genome strain is negligi ble, as it is almost indistinguishable from the sequenc ing error rate 112 . Also, the variation between mice of the same strain, but created from different centres, is very low (fewer than 10,000 SNPs 114 ), although phenotypic differences in behaviour have been reported due to subtle genetic differences between substrains and to environmental factors, such as the order of testing and intertest interval 115, 116 . Interstrain variation, however, is more pronounced, with differences of around 4 million to 5 million SNPs between the mouse reference genome and any other classical inbred strain 114, 117 ; considering that these SNPs are limited to the 85% of uniquely map pable genomic sequences and that the mouse genome is smaller than the human genome, this variation is higher than interindividual variation among humans. Finally, the mouse reference genome differs from other wildderived strains by at least 17 million SNPs, with the exception of strains derived from M. m. domesticus 114 .
In analogy to genetic variation, there is relatively little variation between classical inbred strains [118] [119] [120] and between individuals of the same strain 121 in terms of gene expression in comparable tissues. Differences in gene expression are not necessarily related to the diverse genetic background, as many environmental factors (for example, progressive removal of littermates from the cage) can temporarily alter the gene expres sion profiles of individual mice 121 . Thus, to understand mouse intraspecific variation and to make effective comparisons with humans, it is important to select a suitable mouse population -possibly one that has been outbred from wildcaught mice. The Mouse Phenome Database, which originally integrated phenotype data from 40 inbred strains, has recently started to introduce data from Collaborative Cross and Diversity Outbred mice 122 . These mice present extensive genetic variation from eight founder inbred strains, and various molecular data are collected from them to understand the impact of genotypic diversity in mice 122 . This approach recently led to the identification of 4,188 mouse expression quantitative trait loci (eQTLs) 123 . The identification of causal variants in mice can help to tailor mouse models with specific mutations to humanrelevant phenotypes inserted into a defined genetic background. However, this will require a comprehensive mapping of eQTLs from one species to the other, which is still lacking, to the best of our knowledge. Nonetheless, a comparison of CD4 + T cells from healthy humans and from a panel of the most com mon inbred mouse strains found significant overlap of orthologous genes affected by eQTLs 120 . The use of inbred strains to uncover relationships between genotype and gene expression is more suited to experiments on allele-specific expression than those aimed at comparing transcriptomes. In hybrid mice generated from two distinct inbred strains, maternal and paternal genotypes can be readily tracked. In fact, with more than 450 inbred strains 111 , carefully annotated by the Jackson Laboratory 5 , RNA production from only one allele can be easily detected and compared across multiple tissues 114, 124 . Cellular complexity of mammalian organs A vast proportion of transcriptomics studies in human and mouse, especially comparative ones, have been focused on profiling gene expression at the organ or tissue level. Thus, organs have been regarded as the functional units of organisms, each one with its own distinct transcriptional pattern. However, organs are composed of an organized mixture of different cell types, the concerted genomic activity of which establishes the proper functioning of the organ as a whole. Currently, it is unknown how many different cell types compose mammalian organisms. So far, more than 400 human cell types have been classified 125 on the basis of multiple criteria, including morphology and biochemistry. The diverse composition and relative proportion of cell types in an organ can be a potential source of unwanted var iation in gene expression between organs and between species 126 (FIG. 3) . In fact, theoretically, even two dis tinct samples from the same biopsy, but from different histological sections, can exhibit distinct gene expression profiles owing to the diversity in celltype composition. For example, clustering analyses have revealed that pop ulations of human and mouse primary cells of a given type have distinctive expression profiles 127, 128 . Therefore, it is extremely important to deconvolute qualitatively and quantitatively which cell populations contribute to the global expression patterns of organs 129 .
Most transcriptomics studies on mammalian pri mary cells are based on metaanalyses, largely of micro array data from disparate sources, which, despite the use of normalization methods, carry technical noise and reduced sensitivity. The FANTOM Consortium has released the largest organized atlas of promoter (and gene) expression data 15 from hundreds of human and mouse primary cells and tissues. However, a sys tematic comparative analysis between the two species, including a large panel of cell types and conditions, is still lacking at the resolution of cell populations. Such an analysis could shed light on celltypespecific differences between human and mouse that are masked by the average behaviour of whole organs. For instance, two genes that are expressed in the α and βcells of pancreatic islets, GC (encoding groupspecific compo nent (vitamin D binding protein)) and DLK1 (encoding deltalike noncanonical Notch ligand 1), have opposite cellspecific expression in human and mouse 130 . Expression data from purified populations of pri mary cells provide higher resolution than wholetissue transcriptomes, being robust to stochastic variability between cells 131 . Recent advancements in singlecell technologies 132, 133 , such as singlecell RNAseq, have enabled researchers to obtain gene expression data for rare cell types, the signals of which are usually masked at the population level. This facilitates the identification of novel cell types with previously unknown markers and the characterization of cell differentiation stages 134 .
Because of the difficulty of disaggregating human solid tissues, most singlecell RNAseq research has focused on mouse solid tissues, including brain 135 , lung 136 and intestine 137 , although a small number of studies have analysed human samples from pancreatic islets 130 , brain 138 and blood 139, 140 tissue. The Human Cell Atlas Consortium has been formed to create comprehensive reference maps of all human cells using multiple molec ular assays, including RNAseq. Additionally, singlecell RNAseq has been applied to investigate RNA dynamics over time, especially in the early stages of life. For exam ple, more than 1,000 single cells from the mouse epiblast were collected in a study of early gastrulation at embry onic day 6.5 to 7.75 to investigate mesodermal lineage differentiation towards the haematopoietic system 141 . Despite the growing number of projects using single cell RNAseq, as with cell population data, very few compare human and mouse singlecell expression. One complication may be the intrinsic difficulty of obtain ing comparable samples from homologous organs or identifying homologous dynamic processes. A recent study compared the genetic programmes of human and mouse early embryos during the developmental stages between oocytes and morula 142 . The authors observed that although global gene expression profiles were con served, the actual developmental timing of expression differed between the two species 142 . Ultimately, compar ing human and mouse transcriptomes at the singlecell level will help to identify previously undescribed con served cell types, overcome the biases of different celltype composition and help us to understand the conserved and diverged elements of temporal dynamics. 
Ischaemic time
In the case of organ donors, the time elapsed between the death of a donor and the organ extraction.
Pseudogenes
Segments of DNA that originate from functional genes, but have lost at least some of the ability of the parent gene in terms of expression or coding potential.
However, this will require the development of specific computational methods that deal with the complexity of singlecell data and integrate it with the additional dimension of crossspecies comparison.
Conclusions and perspectives
The rise of nextgeneration sequencing technologies in the past few years has considerably advanced the field of comparative genomics, transcriptomics and epig enomics. These approaches are particularly important for studying the evolution of gene regulation in model organisms and gaining deeper insights into the degree of their conservation with humans at the molecular level, as well as how this conservation correlates with conserva tion at the phenotypic level. Ultimately, this knowledge can help us to understand to what extent a given animal model is suitable for the study of a specific biological process or condition. A considerable amount of work, including efforts from international consortium projects such as Mouse ENCODE 17 and FANTOM 15 , has been centred on the laboratory mouse owing to its indisputable relevance as a model for human biology and diseases. Emerging from this wealth of data is a complex picture that underlies the difficulties associated with mapping the conservation of transcriptional patterns to the conservation of pheno typic traits. At the root of the problem is the difficulty of matching phenotypes across species, and therefore of quantifying phenotypic differences between species, which can then be correlated to transcriptional dif ferences. This is even the case for apparently straight forward phenotypes, such as those affecting individual tissues, organs or anatomical sites. Indeed, tissues are complex structures that are composed of many primary cell types, and it is unclear whether equivalent cell types remain orthologous, to what extent the relative abun dances of the populations of these cells types have been conserved among the species or whether the tissue sam ple sectioned in the different species retains the same underlying tissue substructure.
Moreover, gene expression is affected by an almost unlimited number of biological factors, including sex 143 , age 144 , circadian rhythms (recent research suggests that about half of all mammalian genes are subject to circ adian regulation 145 ), ischaemic time and RNA integrity 146 , and environmental factors. Many of these biological fac tors are difficult to control, even when analysing appar ently orthologous tissues. If, for instance, the biological age or the time of day at which the tissues have been collected differ between species, this may artificially exaggerate transcriptional differences beyond those that can be uniquely attributed to the species. This problem may be exacerbated in the case of more complex pheno types, such as developmental or differentiation pro cesses, response to external stimuli or insults, behaviour or systemic diseases. Hence, because it is technically difficult to identify orthologous phenotypes, transcrip tomes monitored in different species are likely to over estimate the true interspecies transcriptional differences.
Singlecell genomics may contribute to addressing some of these issues. The unbiased identification of populations of cells sharing a similar phenotype could help to match these populations across species (that is, by using orthologous specific markers). In addition, new methodologies are emerging that preserve spa tial information about the tissue context or subcellular localization of analysed nucleic acids 147 . Although spatial transcriptomics is still in its early days 148, 149 , it carries the promise of revolutionizing the way multicellular com plexes, such as organs, are studied and might reveal new insights into the conservation of multicellularcomplex organization between human and mouse. This should lead to more biologically meaningful transcriptome comparisons.
By contrast, most comparative transcriptome stud ies have focused on the patterns of gene expression of proteincoding genes: that is, on the genomic ele ments that are most strongly conserved across spe cies. However, lncRNAs, as well as other noncoding transcriptional elements such as small RNAs, pseudogenes and repetitive elements, are emerging as important play ers in the biology of organisms. These elements are less conserved across species than proteincoding genes, and their orthology is difficult to determine or simply does not exist. Generally, they are poorly characterized from the transcriptional standpoint. Because the expression patterns of the noncoding transcriptome are known to be more speciesspecific than those of proteincoding genes 28 , transcriptional comparisons based on the lat ter (the vast majority, so far) are likely to overestimate interspecies similarities. A failure to take such non coding transcription into account may partially explain why findings in some mouse models do not extrapolate well to humans. Remarkably, although the prevalent view is still that proteins are the main effectors of bio logical function, a comprehensive proteomics comparison between human and mouse is still lacking, with available studies being so far limited to a few specific samples 150 . Monitoring more transcriptomic elements, ortho lo gous conditions and phenotypes will in practice generate a large (almost infinite) data matrix 151 . In this matrix, rows are conditions and columns are genomic elements (such as genes, transcripts and other transcriptional elements, but also epigenomic elements such as tran scriptionfactorbinding sites or histone modifications). A third dimension represents the species, and a fourth dimension represents dynamic processes (FIG. 4) . The matrix is currently quite sparse, even when considering only human and mouse. For instance, there is little com parative data about transcriptional changes associated with processes occurring over time, such as differentia tion and development 152, 153 , or with cellular and organis mic responses to external stimuli. Indeed, there is some evidence that inducible genes might be responsible for gene expression divergence between species 61 , although such genes are more challenging to identify because similar perturbations need to be applied on homolo gous systems. This could be especially important for clinical studies, for example, to study the time of physi ological responses to drugs or the progression of a dis ease. The deconvolution of such a data matrix, which is certainly challenging from an analytical standpoint, will contribute to understanding the transcriptome determinants underlying phenotypic similarities and differences between species. Although we are still far from such a goal, the data currently available, which we have reviewed here, strongly suggest that the question of whether the mouse is overall a good model of human biology is illposed and does not have a binary answer. It clearly depends on the phenotype of interest, the genes involved in the phenotype and the tissues and organs in which these genes are expressed. In the era of precision medicine, each individual may come to have his or her genome sequenced, and possibly be subjected to multiple genomics assays analysing differ ent anatomical sites at different life stages. Thus, we can envision that human-mouse comparisons will eventually be done on a personbyperson basis, and customized mouse models might be generated that are tailored to an individual. Understanding what part of mouse biology (or of the biology of any model organism) can be extrap olated to humans, and under which circumstances, is of crucial importance not only for improving therapeutic interventions but also for optimizing the use of animal models and decreasing the economical and ethical costs associated with animal research. We caution that as many factors as possible should be matched when mouse models are used to study human physiology or disease 65 .
Precision medicine
An emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment and lifestyle for each person.
